Moderna stock pharmaceuticals stock reacting to strong imbalances
Moderna stock MRNA pharmaceutical has started to react to the strong weekly imbalance mentioned in the last update. This biotech company is distributing one of the approved coronavirus vaccines to millions of people around the world. Is Moderna stock MRNA a stock to buy? It definitely has been, as explained in the last Moderna stock...
Pfizer PFE stock buy opportunity in 2021
Was Pfizer stock a great stock to buy in 2021? It actually was, as explained in the previous Pfizer stock analysis. Does Pfizer (NYSE: PFE) stock deserve a place in your portfolio? Sure it does. Moreover, with the strong demand imbalance, that gained control at around $37 per share. Pfizer stock price 2021 Pfizer Inc....
Is Salesforce CRM stock a buy now?
Should you consider investing in Salesforce stock now? The bias is clearly bullish, but as a supply and demand trader, you would be late now that the monthly demand imbalance mentioned in the previous salesforce stock analysis shared with you last 12th October 2020. Salesforce.com stock (NYSE: CRM) has broken all-time highs. There is a...
Learn to trade cryptocurrencies. Cryptocurrency Aave
In the Set and Forget online trading community, you will learn all you need to know about the basics of cryptocurrency. Learn how Bitcoin, blockchain and altcoins like AAVE and others work. Learn how to take advantage of crypto trading trade ideas and opportunities, use them, and why they matter to you. We’re actively trading...
Moderna stock pharmaceuticals stock. Is it a buy?
We might think that Moderna stock pharmaceuticals could be subject to wild swings as this biotech company is attempting to distribute a coronavirus vaccine to millions worldwide. Is Moderna stock MRNA a stock to buy? Moderna stock has been a stock to buy quite a few times in the last few months. As supply and...
Bayer pharmaceutical stock long term buy opportunity
Bayer stock is a life science company trading on the German stock exchanges with the symbol BAYN. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and speciality therapeutics, especially in cardiology, oncology, gynaecology, haematology and ophthalmology, radio-pharmacology and others. The...
EURUSD technical analysis 2021 update
Both EURUSD and US Dollar Index #DXY had reached strong imbalances, as explained in a previous analysis last 12th January 2021. As expected, the EURO has dropped strongly from that strong imbalance in the monthly timeframe. The same is happening to the US Dollar Index but upside down, which is why most US dollar cross...
USDJPY chart. Daily uptrend February 2021
The USDJPY chart is definitely bullish. The daily timeframe is trending up, creating new demand imbalances and respecting them. The bigger picture bias for the USDJPY Forex cross pair is bullish, with the USD potentially becoming stronger, as explained in a previous Dollar Index DXY chart analysis. Why is USDJPY rallying so strongly? The bigger...
Alibaba stock price reacting to a strong imbalance during 2021
Alibaba’s stock price is reacting to a strong demand imbalance on the monthly timeframe as expected and shared with members of the Set and Forget online trading community. Alibaba Group stock took a few months to pull back to the strong imbalance, located around $215 per share, and it’s reacting to it very strongly. Alibaba’s...
Is Pfizer stock a great stock to buy in 2021?
Is Pfizer stock a great stock to buy in 2021? Does Pfizer (NYSE: PFE) stock deserve a place in your portfolio? Sure it does. Moreover, with the strong demand imbalance, that gained control at around $37 per share. For Pfizer (NYSE: PFE), the dividend yield, growth rate, and payout ratio all support the supply and...
Is This The Most Important Bitcoin Price Level of 2025?
April 22, 2025
Dogecoin Just Reached a MAJOR Price Floor in 2025!
April 22, 2025
Breaking Down XRP Monthly Charts For HUGE Gains!
April 18, 2025
TRON TRX Crypto Price Reached A Critical Level in 2025
April 10, 2025
© 2013 – 2025
Set and Forget S.L
All Rights Reserved.
Follow Us
Disclaimer
Any Advice or information on this website is General Advice Only - It does not take into account your personal circumstances, please do not trade or invest based solely on this information. By viewing any material or using the information within this site you agree that this is general education material and you will not hold any person or entity responsible for loss or damages resulting from the content or general advice provided here by Set and Forget, its employees, or fellow members. Futures, options, and spot currency and stocks trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the Forex and futures markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell spot Forex, cfd's, stocks or other financial products. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in any material on this website. The past performance of any trading system or methodology is not necessarily indicative of future results.
High Risk Warning: Forex, Futures, and Options trading has large potential rewards, but also large potential risks. The high degree of leverage can work against you as well as for you. You must be aware of the risks of investing in Forex, futures, and options and be willing to accept them in order to trade in these markets. Forex trading involves substantial risk of loss and is not suitable for all investors. Please do not trade with borrowed money or money you cannot afford to lose. Any opinions, news, research, analysis, prices, or other information contained on this website is provided as general market commentary and does not constitute investment advice. We will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from the use of or reliance on such information. Please remember that the past performance of any trading system or methodology is not necessarily indicative of future results.